Phase II Study of Ixabepilone in Metastatic Breast Cancer and Its Effects on the Ultrastructure of Neurons
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: ixabepilone
Sponsor: Weill Medical College of Cornell University
Collaborators: Bristol-Myers Squibb